Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children
This study is ongoing, but not recruiting participants.
Study NCT00491985   Information provided by Sanofi-Aventis
First Received: June 26, 2007   Last Updated: September 22, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Influenza
Orthomyxoviridae Infections
Influenza A Virus Infection
Additional conditions recognized in this trial
Communicable Diseases
Infection
Influenza, Human
Virus Diseases
More general conditions related to this trial
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services